Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials

医学 心力衰竭 内科学 危险系数 射血分数 心脏病学 射血分数保留的心力衰竭 置信区间 随机对照试验 人口 环境卫生
作者
Nima Moghaddam,Navraj Malhi,Mustafa Toma
出处
期刊:American Heart Journal [Elsevier BV]
卷期号:241: 74-82 被引量:11
标识
DOI:10.1016/j.ahj.2021.07.003
摘要

Soluble guanylate cyclase (sGC) stimulators are a novel class of medications with emerging role in heart failure (HF). The aim of this study is to evaluate the efficacy and safety of oral sGC stimulators in patients with HF with reduced and preserved ejection fraction (HFrEF and HFpEF) by pooling data from all available randomized control trials (RCT).A comprehensive search of electronic databases from 2000-2020 was performed. Seven RCTs, three HFrEF and four HFpEF studies, were identified. The follow-up duration ranged from 1 month to a median of 10.8 months. A random-effects meta-analysis was conducted to summarize the studies.The study population included 7190 patients: 5707 HFrEF and 1483 HFpEF patients. In HFrEF, oral sGC stimulators reduced the composite incidence of HF hospitalization and cardiovascular death (hazard ratio [HR] 0.87, 95% confidence interval [CI] 0.78-0.97; I2 = 0%), primarily driven by lower HF hospitalization (HR 0.88, 95% CI 0.78-0.99; I2 = 0%). There was no significant reduction in all-cause death in HFrEF (HR 0.95, 95% CI 0.83-1.09; I2 = 0%). In HFpEF, there were no improvements in Kansas City Cardiomyopathy Questionnaire clinical summary scores (mean difference 0.81, 95% CI -2.16-3.77; I2 = 72%) or 6-minute walk distance (mean difference 3.34 meters, 95% CI -7.86-14.54; I2 = 28%). There was no difference in all-cause mortality in HFpEF (HR 1.94, 95% CI 0.92-4.09; I2 = 0%). Overall, oral sGC stimulators had low medication-related serious adverse events.Oral sGC stimulators are well tolerated in HF and reduce the incidence of HF hospitalization but not cardiovascular death among patients with HFrEF. However, there are no apparent benefits in HFpEF.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
饱饱完成签到,获得积分10
1秒前
Ava的应助被独特忆南采纳,获得10
1秒前
1秒前
1秒前
3秒前
怡然缘分发布了新的文献求助10
3秒前
天天快乐的应助被蛋又白采纳,获得10
3秒前
DW的应助被leo采纳,获得10
4秒前
赘婿的应助被科研通管家采纳,获得10
5秒前
5秒前
null的应助被AAA采纳,获得10
6秒前
所所的应助被科研通管家采纳,获得10
6秒前
null的应助被科研通管家采纳,获得10
7秒前
xtt121的应助被科研通管家采纳,获得10
7秒前
7秒前
深情安青的应助被西柏采纳,获得10
7秒前
xtt121的应助被科研通管家采纳,获得10
7秒前
bkagyin的应助被15274887998采纳,获得10
7秒前
wanci的应助被科研通管家采纳,获得10
7秒前
斯文败类的应助被科研通管家采纳,获得30
7秒前
Orange的应助被科研通管家采纳,获得10
7秒前
斯文败类的应助被科研通管家采纳,获得10
7秒前
秋风的应助被科研通管家采纳,获得10
8秒前
李爱国的应助被科研通管家采纳,获得10
8秒前
molihuakai的应助被科研通管家采纳,获得10
8秒前
SciGPT的应助被科研通管家采纳,获得10
8秒前
英姑的应助被科研通管家采纳,获得10
8秒前
Ziezer发布了新的文献求助10
8秒前
8秒前
8秒前
无花果的应助被科研通管家采纳,获得10
8秒前
8秒前
酷波er的应助被科研通管家采纳,获得10
8秒前
元宵发布了新的文献求助10
9秒前
CipherSage的应助被彩色的哈密瓜采纳,获得10
9秒前
石永怡关注了科研通微信公众号
9秒前
MOLLY完成签到 ,获得积分10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178280
求助须知:如何正确求助?哪些是违规求助? 9569046
关于积分的说明 21802436
捐赠科研通 7773138
什么是DOI,文献DOI怎么找? 3432735
关于科研通互助平台的介绍 2556770
邀请新用户注册赠送积分活动 2478274